The World Market for Molecular Diagnostics, 7th Edition (Infectious Disease, Cancer, NAT Blood Screening, Transplantation, Histology/Cytology, Inherited Diseases)

  • ID: 4071586
  • Report
  • Region: Global
  • 353 Pages
  • Kalorama Information
1 of 5
What is The Size of the Molecular Diagnostics Market in 2017?

FEATURED COMPANIES

  • Abbott Diagnostics
  • Applied Spectral Imaging
  • Bio-Rad Laboratories
  • Exosome Diagnostics
  • Immucor
  • Qiagen
  • MORE

This report, The World Market for Molecular Diagnostics, 7th Edition, examines the current state for molecular assays, including cancer tests, NAT blood screening, transplantation testing, histology testing and inherited disease testing. Market size and forecasts are provided to 2021 for major segments and several subsegments. Profiles of operators and market share is provided.

As part of its coverage, the following market estimates are included in this report:

  • Microbiology Market, 2016-2021
  • Oncology Testing Market 2016-2021
  • Blood Screening Market 2016-2012
  • Hepatitis Test Market  HIV Diagnostics Market, 2016 to 2021
  • HAIs/Sepsis Market, 2016 to 2021
  • CT/NG Diagnostics Market, 2016 to 2021
  • HPV Diagnostics Market, 2016 to 2021
  • RSV Diagnostics Market, 2016 to 2021
  • Mycobacteria/TB Molecular Diagnostics Market, 2016 to 2021
  • Other Infectious Disease Molecular Diagnostics Market, 2016 to 2021
  • ISH Market by Application: Genetic, Cancer, Other, 2016 to 2021
  • Other Histology Molecular Diagnostics Market, 2016 to 2021
  • Inherited Diseases Molecular Diagnostics Market, 2016 to 2021
  • Transplant Diagnostics Market, 2016 to 2021

The major applications of clinical molecular diagnostics include: Infectious disease diagnostics such as molecular microbiology and virology, including the detection, identification, quantification and nucleic-acid based resistance or susceptibility profiling of pathogens; Blood Transfusion Diagnostics, nucleic acid screening (NAT) of donated blood, often pooled samples, for the detection of active infections responsible for transfusion transmitted infections (TTIs); ancillary market for molecular immunohematology or blood typing; Histology / cytology diagnostics , which is largely synonymous with in situ hybridization (ISH) methods that use direct hybridization of chromogenic (CISH) or fluorescent (FISH) nucleic acid probes within slided tissue or suspended cell samples viewed under microscopy;Molecular Cancer Diagnostics, which are tissue, blood and urine samples can be assayed using nucleic acid amplification tests (NAATs) or sequencing to diagnose, prognose and identify key mutations for targeted therapies; future; Transplant diagnostics - various PCR-based methodologies, Sanger sequencing and NGS used to type HLA alleles in low to high resolution in order to match donors and recipients for solid organ and hematopoietic stem cell (HSCT) or bone marrow transplants, as well as post-transplant monitoring. The report also covers Inherited disease diagnostics - diagnosis of rare genetic diseases andother inherited traits including pharmacodiagnostic (pharmacokinetic) traits;major area of application is thrombophilia markers and anticoagulant response markers

Infectious disease is projected to account for 60% of the global molecular diagnostics market by 2021.The market segment is defined by test decentralization with the introduction of NAAT platforms able to be operated in hospital labs and near-patient points of care such as physician office labs (POLs) and outpatient clinics. Integrated design from sample preparation to results analysis and user friendly features are just as appealing to larger clinical labs to free up personnel. Menu expansion on integrated analyzers has been the predominant focus of competitors in molecular infectious disease diagnostics. Market share and client retention depend on the ability of one platform to perform all routine infectious disease tests.

The development of molecular tests has been prioritized for all recent disease threats, notably Ebola and Zika virus. While immunoassays are preferred for routine screening and by cost-constrained labs, molecular tests offer optimal sensitivity and specificity key to public health response,diagnosis, and targeted treatment. Infectious diseases range from the common flu to antimicrobial resistant inpatient infections and engage all levels of healthcare and thus represent the largest market for molecular diagnostics.

Molecular Diagnostics Market Share Analysis: Who's in the Lead?

Roche Diagnostics has been an unmovable leader.  The company’s resources and history in the market have allowed it to adapt and diversify as needed, most recently with its Liat system for CLIA-waived molecular infectious disease testing, HPV assay FDA-approved for primary screening, and new viral load assays for its cobas6800/8800 core lab virology systems.There are a great number of companies participating in these segments of molecular diagnostics, from molecular specialists to the top-tier IVD companies.

 The report identifies market share not only for the overall molecular diagnostics market but for molecular test categories, including:

  •  Blood Testing Market Share Analysis
  • Cancer Testing Market Share Analysis
  • Transplantation Market Share Analysis
  • Infectious Disease Market Share Analysis
  • Disease Testing Market Share Analysis

The segmented market share allows competitors and interested market-watchers to see not only how a company is performing in the overall molecular diagnostics market, but also in their specialty area. To assist in global business planning efforts, this report contains market sizing and forecasts to 2021 for major world regions including the United States, Europe, Japan, China and Latin America.  

The future of the molecular diagnostics market lies with nucleic acid amplification tests and sequencing-based tests. Time to results for real-time PCR and isothermal amplification are crucial for several infectious disease testing applications including respiratory testing,hospital-acquired infections, bloodstream infections, and molecular point-of-care tests. These trends are discussed in the report.

READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Abbott Diagnostics
  • Applied Spectral Imaging
  • Bio-Rad Laboratories
  • Exosome Diagnostics
  • Immucor
  • Qiagen
  • MORE

ONE: EXECUTIVE SUMMARY
Introduction
Scope and Methodology
Report Design
Size and Growth of the Market
Market Trends

TWO: INTRODUCTION
Background
The Buzz Is On
DTC in 2015 - Building Evidence
Sequencing Enters the Clinic
Exome Sequencing
Metabolomic Profiling
Liquid Biopsy
Information Technology Brings Clarity
Forensic Studies - An Emerging Opportunity
Multi-omic IT
Molecular Test Expansion Supported by Quality Measures
Test Platforms
Tests and Technologies in 2014
Molecular Diagnostics and Target Markets

THREE: DELIVERING MOLECULAR TESTS TO THE CLINIC
Background
The Reimbursement Environment
Physician Uptake
The U.S. Experience
Personalized Precision Medicine Advances and Barriers
The Service Industry Is Here to Stay

FOUR: SEQUENCING - HOW FAR CAN WE GO?
Background
Companies and Technologies
Market Analysis
Sequencing Research Projects
Cancer More Personalized
Pathogen Sequencing

FIVE: MARKET ANALYSIS: WORLD MARKETS
Background
Worldwide Opportunities for Molecular Tests

The United States of America
Canada
Europe
China

SIX: THE MARKET FOR BLOOD MARKERS IN CANCER
Introduction
Precision Medicine and a New Molecular Perception
Back to the Status Quo

SEVEN: THE MARKET FOR MOLECULAR ASSAYS IN HEMATOLOGY: CELL-BASED MOLECULAR TESTS
Flow Cytometry
Market Analysis

EIGHT: THE MARKET FOR MOLECULAR ASSAYS IN COAGULATION
Thrombophilia SNPs
Pharmacodiagnostics

NINE: HISTOLOGY AND CYTOLOGY
Background
Advanced Analysis Tools
Sample Preparation
In Situ Hybridization
HPV Testing
Circulating Tumor Cells
Pharmacodiagnostic Histology

TEN: MICROBIOLOGY AND VIROLOGY
Introduction
Market Overview
POC and Decentralized Testing
Sample Preparation
Test Services
Antimicrobial Drug Resistance
Next Generation Sequencing in Microbiology
The Human Microbiome
Emerging Disease Threats
Blood Culture & Hospital Acquired Infections
HIV
Hepatitis
Sexually Transmitted Diseases (STDs)
Respiratory Tract Infections
Tuberculosis
Fungal Infections
Miscellaneous Tests

ELEVEN: THE MARKET FOR MOLECULAR ASSAYS IN BLOOD TRANSFUSION MEDICINE
Blood Pathogen Screening
Blood Typing

TWELVE: THE MARKET FOR MOLECULAR ASSAYS IN ORGAN TRANSPLANT MANAGEMENT
Technological Advancements
Market Analysis

THIRTEEN: THE MARKET FOR MOLECULAR ASSAYS IN PRENATAL AND NEWBORN SCREENING
Introduction and Market Data
cfNIPT - Perception, Perception, Perception
Parental Carrier Screening
In Vitro Fertilization
cfDNA Market Expansion
Newborn Screening

FOURTEEN: THE MARKET FOR MOLECULAR ASSAYS FOR INHERITED DISEASES
Autism
Alzheimer’s Disease
Cardiovascular Disease
Diabetes
Psychiatric Disorders
Gastrointestinal Conditions
Rare Diseases

FIFTEEN: CONCLUSIONS AND STRATEGIC IMPLICATIONS
LDTs to Market Cleared Tests

Esoteric Testing Scenario in Europe

Future Outlook
Strategic Implications

SIXTEEN: MAJOR VENDORS AND COMPANIES TO WATCH
Market Drivers and Leaders

Review of Top Companies

Acquisitions, Alliances and Collaborations
Looking Beyond Borders

SEVENTEEN: COMPANY PROFILES: THE TOP TIER
Abbott Diagnostics

IntelligentMDx Alliance
PLEX-ID
Iridica
Histology

Alere Inc.
Beckman Coulter, Inc. / Danaher

Lab Services
Sequencing
Genomics
Information Technology

Becton, Dickinson and Company (BD)

The BD MAX Enterprise
Oncology
HPV
Sequencing
Initiatives
Mass Spectrometry
Flow Spectrometry

Bio-Rad Laboratories, Inc.

Controls
Digital PCR

bioMérieux Inc

Expansion
Oncology
Molecular Strategy
Sequencing Service

Danaher Corporation
General Electric - GE Healthcare

Clarient Diagnostic Services, Inc.

Hologic, Inc.

Product News
The Gen-Probe Business
Panther System
Blood Bank
Quest Contract

QIAGEN N.V.

Personalized Healthcare
Infectious Disease Testing
Transplant Medicine and HAIs
HPV
Companion Diagnostics
Liquid Biopsy/CTC
Instrumentation Base
Rotor-Gene Q - Clinical Diagnostics
Sequencing
Exosomes
Information Technology
Collaborations
Forensics

Roche Diagnostics

New Enterprises
Global Access Program for HIV
Core Molecular Tests
STDs
A POC Enterprise - Liat
Prenatal and cfDNA
HPV
Blood Bank
Liquid Biopsy
Sequencing - Putting the Pieces Together

Siemens Healthcare Diagnostics

Histology
Molecular
Companion Diagnostics
Sequencing
China

Sysmex Corporation

Inostics GmbH
Intraoperative Test
Flow Cytometry

Thermo Fisher Scientific Inc.

Molecular Microbiology
Microbiology IT
Transplant
Quality Control
Mass Spectrometry

EIGHTEEN: COMPANY PROFILES: MAJOR MOLECULAR COMPANIES
Affymetrix Inc.
Agilent Technologies

Agilent in Genomics
PCR
Sequencing
Arrays
Sample Management
Mass Spectrometry
Expansion

Asuragen Inc.

Controls
Sample Collection
Sequencing

BGI

With Complete Genomics
BGI Projects

Cepheid

Hospital Acquired Infections (HAI)
TB
Infectious Diseases
Virology
Oncology

Eiken Chemical Co., Ltd
Enzo Biochem Inc.

IP Situation

Illumina

Sequencing
Sequencing Kits
Sample Prep
IVD Business
Oncology
HLA Typing
IT
Forensics
CLIA Lab Service
Nanopore Sequencing
Sample to Insight
Making a Market
IP Situation

Life Technologies Corporation

Instrumentation and Applications
Liquid Biopsy
Sequencing
Life Technologies an IVD Company
Partnerships Worldwide
Life and Quidel Develop Diagnostics on the 7500 Fast Dx
Sepsis
HIV
Emerging Pathogens
Bacterial Typing
Personalized Medicine
Forensic

PerkinElmer, Inc. (PE)

Newborn Testing
Prenatal Testing
Sequencing
Mass Spectrometry
Information Technology
China

RainDance Technologies, Inc.

Market Expansion

NINETEEN: COMPANY PROFILES: PARTICIPANTS
AutoGenomics Inc.
Biocartis SA

Connectivity
Instrumentation
Collaborations
Idylla News

DiaSorin S.p.A
EKF Diagnostics Holdings Plc
ELITech Group
Epigenomics
Exosome Diagnostics, Inc.
Fluidigm Corporation
Fujirebio Diagnostics, Inc.
GenMark Diagnostics
Genome Diagnostics BV (GenDx)
Luminex Corporation

Business Expansion
MAGPIX Multiplexing
Next Generation NxTag
Product News

Menarini Diagnostics
Nanostring Technologies, Inc.

Alliances
LDTs

Pacific Biosciences of California, Inc. (PacBio)
Quidel Corporation

Lyra Product Line
Solana Molecular System
AmpliVue Product Line
Savanna (formerly Wildcat)
Acquisitions

Rubicon Genomics, Inc.
Transgenomic, Inc.

Alliances
Lab Services
Diagnostic Tools Division

TrovaGene, Inc.
WaferGen Bio-systems, Inc.

TWENTY: COMPANY PROFILES: GREAT EXPECTATIONS
Genomic Vision
GENOMICA S.A.U.
IncellDx, Inc.
Inivata
IntegenX Inc
Linkage Biosciences, Inc.
Savyon Diagnostics
Selventa
VolitionRx Limited

TWENTY-ONE: COMPANY PROFILES: NEWCOMERS
B Braun CeGaT, LLC
Canon BioMedical, Inc.
DestiNA Genomics Ltd
DiamiR, LLC
Randox Laboratories Ltd.

TWENTY-TWO: COMPANY PROFILES: TEST SERVICE PROVIDERS
23andMe

What a Difference a Few Years Makes
The Move to Building a Research Company
Therapeutics Group
Ancestry
Outside the U.S.

Adaptive Biotechnologies Corporation
Agendia BV
AltheaDx Diagnostics, Inc.
Ambry Genetics

Oncology
Cardiac
Prenatal
Information Technology

ARUP Laboratories
Assurex Health
Athena Diagnostics
Bio-Reference Laboratories, Inc. (BRLI)
bioTheranostics
Cancer Genetics, Inc. (CGI)

The Response Genetics Acquisition

CareDx, Inc.
Caris Life Sciences
Centogene AG
Complete Genomics
Counsyl
Exact Sciences Corp.
Foundation Medicine Inc.
Genomic Health, Inc.

Market Uptake
Sequencing
Liquid Biopsy
Service Spin Off

Helomics Corporation
IntegraGen
Invitae Corporation
LabCorp, Laboratory Corporation of America

Infectious Diseases
Prenatal
Sequencing
Oncology
BRCA Saga
Information Technology
Forensic
Collaborations

Mayo Medical Laboratories

Information Technology

MDxHealth SA
Myriad Genetics

Product News
Companion Tests
Beyond Cancer
The U.S. Market
IP Update

Pathway Genomics Corporation
Quest Diagnostics

Oncology
Toxicology
Prenatal and Women’s Health
Market Expansion
Quest Partners for Market Accessibility

Rosetta Genomics Ltd.

Expansion

Veracyte, Inc.

TWENTY-THREE: COMPANY PROFILES: POINT OF CARE TEST SPECIALISTS
Atlas Genetics Ltd.
Biomeme, Inc.
DiAssess Inc
DNA Electronics Ltd (DNAe)
Enigma Diagnostics Limited
Entopsis
Epistem Holdings plc
InSilixa Inc.
Lucigen
PositiveID Corporation
QuantuMDx Group Limited
Rheonix, Inc.
Scanogen Inc.
Ubiquitome
Veredus Laboratories Pte Ltd
Xagenic

TWENTY-FOUR: COMPANY PROFILES: SAMPLE PREPARATION
Horizon Discovery Group plc
MO BIO Laboratories, Inc.
PreAnalytiX GmbH
QIAGEN N.V.
SeraCare Life Sciences, Inc.

TWENTY-FIVE: COMPANY PROFILES: INFORMATION TECHNOLOGY SPECIALISTS
Advaita Bioinformatics
Apple Inc.
Cartagenia
Cerner Corp.
CLC bio
CollabRx Inc.
DNAnexus
GENALICE
GenomOncology
Google Genomics
IBM Healthcare
Intel Corporation
Knome Inc.

Collaborations

N-of-One
PierianDx
Sophia Genetics

TWENTY-SIX: COMPANY PROFILES: HISTOPATHOLOGY SPECIALISTS
Advanced Cell Diagnostics (ACD)
Amoy Diagnostics Co. Ltd.
Applied Spectral Imaging Inc. (ASI)
BioView Ltd.
Circulomics Inc.
Covaris Inc.
Cymogen Dx, LLC
Dako A/S

Companion Diagnostics
Digital Imaging
Flow Cytometry
Automation
Alliances

Definiens
DxTerity Diagnostics Inc.
HTG Molecular Diagnostics
Leica Biosystems

Companion Diagnostics

PreTect AS (formerly Norchip)
Kapa Biosystems Inc.
Ventana Medical Systems Inc.

Digital Pathology
Virtuoso Software Update
Product News
Automation
China
Partnerships

TWENTY-SEVEN: COMPANY PROFILES: MICROBIOLOGY SPECIALISTS
Accelerate Diagnostics, Inc.
Advanced Biological Laboratories, S.A. (ABL)
AdvanDx, Inc.
altona Diagnostics
Aperiomics
Co-Diagnostics HBDC
Curetis AG
DxNA, LLC
Fast-Track Diagnostics
Focus Diagnostics, Inc.
Genetic Analysis AS
Great Basin Scientific, Inc.
Greiner Bio-One International GmbH
Hain Lifescience GmbH
Hutman Diagnostics AG
Intelligent Medical Devices, Inc. (IMDx)

Abbott Diagnostics Partnership
Qiagen Partnership

Meridian Bioscience, Inc.

illumigene
Meridian Life Science

Mobidiag Ltd
Molbio Diagnostics Pvt Ltd.
Nanosphere, Inc.
Market Expansion
PathoGenetix, Inc.
Pathogenica
Reference Genomics Inc.
Seegene, Inc.

Instrumentation
Collaborations

Specific Technologies
T2 Biosystems

TWENTY-EIGHT: COMPANY PROFILES: BLOOD BANK SPECIALISTS
AXO Science
Grifols

Blood Transfusion Novartis Business
International Programs

Immucor, Inc.

TWENTY-NINE: COMPANY PROFILES: PRENATAL TEST SERVICE PROVIDERS
Ariosa Diagnostics, Inc.

IP Status

Berry Genomics Co. Ltd
Combimatrix Corp.

Oncology

Good Start Genetics, Inc.
Illumina

IP Issues
Cytogenetics

LifeCodexx AG
Multiplicom N.V.
Natera
Premaitha Health plc
Sequenom Inc

Market Expansion
Product Expansion
IP Issues
Coagulation

THIRTY: COMPANY PROFILES: CTC & LIQUID BIOPSY TEST PROVIDERS
Angle plc
ApoCell, Inc.
Biocept, Inc.

Menu Expansion
Reimbursement

Clearbridge BioMedics
Cynvenio Biosystems, Inc.
Epic
Fluxion Biosciences, Inc.
Genyo - Centre for Genomics
Qiagen Hanover (formerly AdnaGen GmbH)
ScreenCell
Veridex, LLC
WaveSense LLC

LIST OF EXHIBITS:

ONE: EXECUTIVE SUMMARY
Table 1-1: Common Next Generation Molecular Test Traits
Table 1-2: Selected Salient Developments for Now and the Future
Table 1-3: Exchange Rate Fluctuations, 2009-2014 (Europe, Switzerland, UK, Denmark, Sweden, Norway, Japan, Hungary, Singapore, India)
Table 1-4: Worldwide Molecular Test Sales, 2014 and 2019 (Microbiology/Virology Histology, Blood Screening, Coagulation & PGx, Inherited Diseases & PGx, Tissue Typing, Cancer Markers & PGx, CTCs, Total)
Figure 1-1: Worldwide Molecular Test Sales, 2014-2019 (CTCs, Cancer Markers & PGx,Tissue Typing, Inherited Diseases & PGx, Coagulation & PGx, Blood Screening, Histology, Microbiology/Virology)
Table 1-5: Market Penetration of Clinical Molecular Diagnostics by Geographic Area,2014 and 2019 (N. America, W. Europe [EU5], Japan, China, India, ROW, Total)

TWO: INTRODUCTION
Table 2-1: Common Next Generation Molecular Test Traits
Table 2-2: Selected Salient Developments for Now and the Future
Table 2-3: Selected Exosome Sequencing Tests and Services
Table 2-4: Selected Liquid Biopsy Innovations
Table 2-5: Selected IT Innovations in Molecular Diagnostics
Table 2-6: Selected Innovations in Forensic DNA Testing
Table 2-7: Selected Multi-omic Test Innovations
Table 2-8: Selected Sample Preparation Tools, 2015
Table 2-9: Selected Molecular Test Quality Control Standards
Table 2-10: Key Molecular Technologies
Table 2-11: Selected Molecular Test Platform Innovations
Table 2-12: Worldwide Molecular Test Sales, 2014 and 2019 (Microbiology/Virology, Histology, Blood Screening, Coagulation & PGx, Inherited Diseases & PGx, Tissue Typing, Cancer Markers & PGx, CTCs, Total)
Table 2-13: Key Molecular Test Applications and Technologies
Table 2-14: Selected Rapid Molecular Test Innovations, 2013-2015

THREE: DELIVERING MOLECULAR TESTS TO THE CLINIC
Table 3-1: Diseases with Drug Labels
Table 3-2: Selected Drug/Biomarker Targets in the U.S.
Table 3-3: Selected Drugs That Recommend PGx Testing in Europe
Table 3-4: Selected Personalized Medicine Tests, 2013-2015
Table 3-5: Revenues for a Selection of Molecular Test Service Labs Worldwide, 2010-2014
Table 3-6: Selected New Lab Services, 2015

FOUR: SEQUENCING - HOW FAR CAN WE GO?
Figure 4-1: Flatley’s Law
Table 4-1: Major Sequencing Platforms
Table 4-2: Selected Sequencing-Based Test Services

FIVE: MARKET ANALYSIS: WORLD MARKETS
Table 5-1: Selected International Agreements
Table 5-2: Market Penetration of Clinical Molecular Diagnostics, by Geographic Area, 2014 and 2019 (N. America, W. Europe [EU5], Japan, China, India, ROW, Total)

SIX: THE MARKET FOR BLOOD MARKERS IN CANCER
Table 6-1: Selected Sample Preparation Reagents
Table 6-2: Selected Cancer Test Innovations, 2015

SEVEN: THE MARKET FOR MOLECULAR ASSAYS IN HEMATOLOGY: CELL-BASED MOLECULAR TESTS

Table 7-1: Selected Innovations in Molecular Cell-Based Tests
EIGHT: THE MARKET FOR MOLECULAR ASSAYS IN COAGULATION
Table 8-1: Selected Molecular Pharmacodiagnostics for Anticoagulant Drug Testing, 2014

NINE: HISTOLOGY AND CYTOLOGY
Table 9-1: Worldwide Molecular Histology Sales, by Type, 2014 and 2019 (In situ hybridization, HPV, Histology Total)
Table 9-2: Selected Molecular Histology Innovations, 2015
Table 9-3: Selected FFPE DNA/RNA Sample Preparation Innovations
Table 9-4: Selected HPV Test Innovations
Table 9-5: Selected Innovations in CTC Technology
Table 9-6: Major Pharmacodiagnostic Markers
Table 9-7: Selected Pharmacodiagnostic Histology Tests

TEN: MICROBIOLOGY AND VIROLOGY
Table 10-1: Molecular Test Sales, Microbiology/Virology, 2014 and 2019 (HAI; HIV; Hepatitis; GC/Chlamydia; Respiratory; Organism ID; Mycobacteria, TB; Others; Total)
Table 10-2: Molecular Infectious Disease Company Sales, 2014
Table 10-3: Selected New Instruments for Molecular Infectious Disease Testing,2015
Table 10-4: Selected Molecular Test Innovations for Decentralized Use
Table 10-5: Selected Molecular Infectious Diseases Sample Treatment Products
Table 10-6: Selected Molecular Infectious Disease Test Services
Table 10-7: Selected Tests for Antibiotic Resistance
Table 10-8: Selected Microbiology Sequencing Innovations
Table 10-9: Selected Microbiome-Based Diagnostics
Table 10-10: Tests with Emergency Use Designation
Table 10-11: Selected Innovations in Emerging Pathogen Testing
Table 10-12: Selected Advanced Techniques for Hospital Acquired Infections
Table 10-13: Selected Recent Molecular HIV Test Innovations
Table 10-14: Selected Molecular Hepatitis Test Innovations
Table 10-15: Selected Molecular STD Test Innovations
Table 10-16: Selected Molecular Tests for Respiratory Tract Infections
Table 10-17: Selected Molecular Tests for TB
Table 10-18: Selected Molecular Tests for Fungal Infections
Table 10-19: Miscellaneous Molecular Infectious Disease Tests, 2013-2015

ELEVEN: THE MARKET FOR MOLECULAR ASSAYS IN BLOOD TRANSFUSION MEDICINE
Table 11-1: Pathogen Commonly Tested in Donated Blood Units
Table 11-2: Selected Pathogen Screening Innovations
Table 11-3: Selected Blood Typing Innovations

TWELVE: THE MARKET FOR MOLECULAR ASSAYS IN ORGAN TRANSPLANT MANAGEMENT
Table 12-1: Selected HLA Typing Test Innovations, 2015
Table 12-2: Selected cfDNA Innovations in Transplant Medicine

THIRTEEN: THE MARKET FOR MOLECULAR ASSAYS IN PRENATAL AND NEWBORN SCREENING
Table 13-1: Revenue Stream of Selected NIPT Service Companies, 2010-2015
Table 13-2: Selected New IVF Services
Table 13-3: Selected Genomic Newborn Screening Services

FOURTEEN: THE MARKET FOR MOLECULAR ASSAYS FOR INHERITED DISEASES
Table 14-1: Most Frequently Requested Genetic Tests
Table 14-2: Selected Autism Test Innovations
Table 14-3: Selected Innovations in Genetic Tests for CVD, 2015
Table 14-4: Selected Molecular Diabetes Tests, 2015
Table 14-5: Selected Innovations in Personalized Tests for Psychiatric Disorders
Table 14-6: Selected Tests for Irritable Bowel Diseases
Table 14-7: Selected Molecular Tests for Inherited Diseases, 2015

SIXTEEN: MAJOR VENDORS AND COMPANIES TO WATCH
Table 16-1: Estimated Revenues of the Top Ten Molecular Test Vendors, 2010-2014
Table 16-2: Estimated Revenues of Selected Molecular Test Vendors, 2010-2014
Table 16-3: Selected Acquisitions in Molecular Diagnostics, 2013-2015
Table 16-4: Selected Collaborations and Licensing Agreements, 2013-2015
Table 16-5: Selected Distribution Agreements, 2013-2015

Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • Abbott Diagnostics
  • Advanced Cell Diagnostics
  • Affymetrix (Thermo Fisher Scientific)
  • Agilent Technologies
  • Alere
  • Amoy Diagnostics
  • Applied Spectral Imaging
  • Beckman Coulter (Danaher)
  • Becton, Dickinson & Co. (BD)
  • Beijing Genomics Institute (BGI)
  • Berry Genomics
  • Biocartis
  • bioMérieux
  • Bio-Rad Laboratories
  • Cepheid (Danaher)
  • Covaris
  • Dako (Agilent Technologies)
  • Eiken Chemical
  • Epigenomics
  • Exosome Diagnostics
  • Genmark Diagnostics
  • Grifols
  • Hologic
  • Illumina
  • Immucor
  • Janssen Diagnostics (Johnson & Johnson)
  • Leica Biosystems (Danaher)
  • Luminex Corporation
  • Meridian Bioscience
  • Nanosphere (Luminex)
  • Nanostring Technologies
  • Qiagen
  • Quidel
  • Roche Diagnostics
  • Siemens Healthcare Diagnostics
  • Thermo Fisher Scientific
  • Vela Diagnostics
  • Ventana Medical Systems (Roche)
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll